Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ring finger protein 148 (RNF148) is a protein-coding gene in humans encoding an E3 ubiquitin-protein ligase that contains a RING finger zinc-binding domain[1][9]. This protein is predicted to localize to intracellular membranes, including the Golgi apparatus, endoplasmic reticulum, and late endosome[1][4]. It is involved in tagging proteins with ubiquitin for proteasomal degradation, contributing to protein homeostasis[1][4][7]. RNF148 is broadly expressed, with highest abundance in testis[10]. Recent studies implicate RNF148 as an oncogene in colorectal cancer, where it promotes tumorigenesis via ubiquitination and degradation of CHAC2; mutations in this gene have also been associated with developmental and epileptic encephalopathy 73[1][6]. No approved drugs target RNF148, nor are there established biomarkers or known clinical safety issues linked to its modulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ring finger protein 148 (RNF148).